ED and PE medicine interactions and urgent symptoms
Review key interaction warnings and recognize symptoms that need urgent medical care.
AI-generated editorial illustration. Packaging varies by market; fine print is approximate.
The full medicine list is often more useful than the most prominent brand name. It should include prescriptions, occasional ED or PE treatments, nonprescription products, supplements and recreational substances. This overview explains the main questions; the supplied product’s complete information remains necessary.
Nitrates and blood-pressure effects
PDE5 reference labels contraindicate nitrates and nitric-oxide donors, including recreational nitrites or “poppers.” Riociguat is also contraindicated in the familiar oral reference labels. These combinations can cause a dangerous fall in blood pressure.
Other blood-pressure medicines and alpha-blockers require a more specific assessment. A clinical trial involving selected men receiving antihypertensive treatment does not establish that every combination is safe. Likewise, a longer tadalafil response window means the medicine can remain relevant to emergency treatment after the encounter ends.
For chest pain, serious breathing difficulty or a severe allergic reaction, seek emergency help. Tell the team the ED medicine and timing. Do not self-administer a nitrate after an ED medicine; the emergency clinician needs that information to choose treatment.
Exposure can change without changing the tablet
CYP3A4-interacting medicines can change exposure to PDE5 drugs. Strong inhibitors are particularly important for avanafil, and the exact restrictions vary by medicine and formulation. A pharmacist should check the named medicines rather than the person trying to recognize an enzyme group from a short list.
Vardenafil also has QT precautions involving rhythm conditions and certain interacting drugs. A switch from film-coated to dissolving treatment can change exposure, even if the printed milligrams are the same. The formulation guide explains that example.
PE ingredients add another review
Dapoxetine, fluoxetine and duloxetine affect serotonin signalling, but differ in persistence and treatment context. Other antidepressants and certain pain or migraine medicines can create serious interactions. Fluoxetine-related activity can persist for weeks, so a recent stop does not settle the question of whether another product can be started.
Dapoxetine’s fainting and alcohol precautions also matter. Its Australian Priligy information advises against PDE5 co-use; selected clinical combination research should not be treated as permission for an unsupervised fixed-combination tablet. The dapoxetine article gives that context.
Local products are not exempt
The Vitaros cream label advises against combination with PDE5 treatment because product-specific safety and efficacy have not been established. Injection and intraurethral alprostadil have different training and local-effect questions. A different delivery route does not remove cardiovascular assessment or prolonged-erection risk.
An erection lasting four hours and sudden loss or decrease of hearing or vision need urgent attention. For possible serotonin syndrome—such as a severe combination of agitation, fever and neuromuscular symptoms—seek urgent assessment rather than trying to resolve an interaction by adjusting tablets yourself. Do not interrupt ongoing antidepressant treatment without a prescriber’s plan.
Sources
14 sources
Checked . ED references checked 2 October 2026; PE reference checked 3 October 2026.
- Ejaculation problems — NHS (UK)
- Viagra product information — European Medicines Agency
- Levitra product information — European Medicines Agency
- Stendra prescribing information — DailyMed, US National Library of Medicine
- Vitaros UK product information — emc (UK)
- viagra uk label
- cialis eu label
- spedra eu label
- priligy au information
- eau pe guideline
- fluoxetine uk label
- duloxetine uk label
- caverject uk label
- muse ireland label